Patients with stroke 1 week after the acute onset were included and randomized treated with dihydroergotoxine mesylate 3 tables daily for 3 months.

• 脑卒中后1周患者,随机服用双氢麦角碱3片/d,服用3个月,以神经功能缺损量表(NFDS)和简易智能量表(MMSE)作为疗效评估指标。